Sharekhan has come out with its second quarter (July-September’ 18) earnings estimates for the Pharma sector. The brokerage house expects Glenmark to report net profit at Rs. 167 crore down 22% year-on-year (up 24.3% quarter-on-quarter).
Net Sales are expected to increase by 5.1 percent Y-o-Y (up 9.5 percent Q-o-Q) to Rs. 2,372.4 crore, according to Sharekhan.
Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
